Anturol

Anturol is a brand name of oxybutynin, approved by the FDA in the following formulation(s):

ANTUROL (oxybutynin - gel, metered; transdermal)

• 
  Manufacturer: ANTARES PHARMA INC
  
  Approval date: December 7, 2011
  
  Strength(s): 3% ^[RLD]

Has a generic version of Anturol been approved?

No. There is currently no therapeutically equivalent version of Anturol available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Anturol. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Anturol.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • December 7, 2014 - NEW PRODUCT
  
  

See also...

• Anturol Consumer Information (Drugs.com)
• Anturol Advanced Consumer Information (Micromedex)
• Oxybutynin Consumer Information (Drugs.com)
• Oxybutynin Consumer Information (Wolters Kluwer)
• Oxybutynin Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Oxybutynin Gel Consumer Information (Wolters Kluwer)
• Oxybutynin Syrup Consumer Information (Wolters Kluwer)
• Oxybutynin System Consumer Information (Wolters Kluwer)
• Oxybutynin Consumer Information (Cerner Multum)
• Oxybutynin topical Consumer Information (Cerner Multum)
• Oxybutynin transdermal Consumer Information (Cerner Multum)
• Oxybutynin Advanced Consumer Information (Micromedex)
• Oxybutynin Transdermal Advanced Consumer Information (Micromedex)
• Oxybutynin Chloride AHFS DI Monographs (ASHP)